{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-032964","form_type":"8-K","ticker":"SLS","cik":"0001390478","company_name":"SELLAS Life Sciences Group, Inc.","filed_at":"2024-03-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.026453+00:00","generated_at":"2026-06-04T23:43:22.817869+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"SELLAS regains Nasdaq minimum bid price compliance effective March 11, 2024","bullets":["Nasdaq confirmed compliance after closing bid price above $1.00 for 10 consecutive business days through March 8, 2024.","Company had been notified of non-compliance on February 14, 2024, and given a 180-day grace period until August 12, 2024.","Non-compliance matter is now closed; no further action required.","This removes a potential delisting risk for SELLAS common stock (SLS)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-032964","json":"https://secwatch.observer/filing/0001104659-24-032964.json","markdown":"https://secwatch.observer/filing/0001104659-24-032964.md","text":"https://secwatch.observer/filing/0001104659-24-032964.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924032964/0001104659-24-032964-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924032964/tm248504d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T23:43:22.817869+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}